Effects of Sleep Body Temperature on Body Composition
1 other identifier
interventional
40
1 country
1
Brief Summary
This will be a crossover controlled trial designed to recruit 40 participants, who will be divided into two groups of 20 subjects each. The participants will be randomly assigned to either Group A or Group B. Group A will receive the sleep electric blanket intervention for a period of 7 days, while Group B will serve as the control group without any additional intervention. After the intervention period, there will be a washout period of 7 days to ensure that any effects of the intervention have subsided before the crossover. Following the washout period, the groups will switch roles: Group B will then receive the sleep electric blanket intervention, and Group A will become the control group. This second phase will also last for 7 days, preceded and followed by the same assessment procedures as the initial phase. This design will allow for a comparison of the intervention's effects against a control period within the same group of participants, enhancing the study's internal validity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2024
CompletedFirst Posted
Study publicly available on registry
October 18, 2024
CompletedStudy Start
First participant enrolled
October 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2025
CompletedOctober 18, 2024
October 1, 2024
3 months
October 15, 2024
October 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Blood pressure
Including systolic blood pressure (SBP) and diastolic blood pressure (DBP), Includes office blood pressure, home blood pressure and ambulatory blood pressure.
1month
Study Arms (2)
Mild-heat group
EXPERIMENTALParticipants will be randomized into groups A and B. When the subject's group cohort undergoes the intervention phase (as opposed to the control phase), they will receive a 7-day, 8-hour intervention with an electric blanket set at +5±1°C above room temperature.
Non-mild-heat group
NO INTERVENTIONParticipants will be randomized into groups A and B. There will be no additional sleep temperature intervention while the group is in the control period.
Interventions
Participants were randomized to groups A and B. When the subject\'s group cohort went through the intervention phase (instead of the control phase), they received a 7-day, 8-hour intervention with an electric blanket +5±1°C above room temperature.
Eligibility Criteria
You may qualify if:
- \- Participants aged 18-30 years, inclusive of both male and female genders.
You may not qualify if:
- Individuals suffering from serious diseases such as heart, liver, kidney, brain, hematopoietic, immune, thyroid, malignant tumors, etc.;
- Those with familial hereditary hypertension (both parents are hypertensive) or those diagnosed with hypertension;
- Individuals with cognitive or mental impairments that prevent the completion of the questionnaire;
- Persons with physical disabilities that hinder normal walking;
- Persons who have experienced a weight change of \>3.0 kg within 1 month or \>10 kg within 6 months prior to screening (as per the study in Nutrients. 2020 Oct 21;12(10):3221);
- Individuals required to take antibiotics from one week before the trial starts until its conclusion;
- Those with habitual diarrhea or who have experienced diarrhea from one week before the trial starts until its end;
- Subjects who have participated in other ambient temperature-related trials within the last 6 months;
- Individuals with extreme sleep schedules (i.e., not falling asleep between 21:00 and 2:00 a.m. the following morning, or waking up before 5:00 a.m.);
- Those with sleep latency (the time it takes to fall asleep after going to bed) greater than one hour;
- Pittsburgh Sleep Quality Index (PSQI) scores greater than 16;
- Participants who do not sign the informed consent form or are deemed unsuitable by the investigator for any other reason.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jinan University Guangzhou
Guangzhou, Select A State, 510632, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 15, 2024
First Posted
October 18, 2024
Study Start
October 20, 2024
Primary Completion
January 30, 2025
Study Completion
January 30, 2025
Last Updated
October 18, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
The experiment will be made public upon completion with the publication of the related paper, sharing: contact the researcher for a copy.